<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9292">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05701137</url>
  </required_header>
  <id_info>
    <org_study_id>2022-03</org_study_id>
    <nct_id>NCT05701137</nct_id>
  </id_info>
  <brief_title>Effectiveness of an EMDR Intervention for Perinatal Loss</brief_title>
  <official_title>Effectiveness of an Eye Movement Desensitization and Reprocessing (EMDR) Intervention for the Prevention of Post-traumatic Symptoms in Perinatal Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EMDR Europe</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators objectives is to assess the effectiveness of Eye Movement Desensitization&#xD;
      and Reprocessing - recent traumatic episode (EMDR-RTE) as a preventive intervention for&#xD;
      Posttraumatic Stress Disorder (PTSD) symptoms after perinatal loss.&#xD;
&#xD;
      The hypothesis is that EMDR-RTE treatment may prevent post-traumatic and depressive symptoms&#xD;
      in women who suffered perinatal loss.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Perinatal loss is a general term that refers to a loss from conception to one month&#xD;
      postpartum. It is a grief that is still socially unauthorized, however, it is a situation&#xD;
      with significant traumatic potential. However, there are no studies evaluating the&#xD;
      effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) for the prevention or&#xD;
      treatment of perinatal loss. We propose an one-site, open label, randomized controlled trial&#xD;
      with the aim of assessing the effectiveness of EMDR recent traumatic episode (EMDR-RTE) as a&#xD;
      preventive intervention for PTSD symptoms after perinatal loss. A total of 40 women who have&#xD;
      suffered a perinatal loss from the Maternal-Fetal Medicine Service of a tertiary university&#xD;
      hospital will be recruited. Women will be randomized to EMDR-RTE or treatment as usual (TAU).&#xD;
      Researchers will compare EMDR-RTE and TAU to see if women receiving EMDR-RTE treatment had&#xD;
      lower levels of post-traumatic and depressive symptoms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2023</start_date>
  <completion_date type="Anticipated">November 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PCL-5</measure>
    <time_frame>Within the first month after perinatal loss</time_frame>
    <description>PTSD Checklist for DSM-5</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCL-5</measure>
    <time_frame>3 months after perinatal loss</time_frame>
    <description>PTSD Checklist for DSM-5</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>STAI S/T</measure>
    <time_frame>Within the first month after perinatal loss</time_frame>
    <description>Spielberger State/Trait Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STAI S/T</measure>
    <time_frame>3 months after perinatal loss</time_frame>
    <description>Spielberger State/Trait Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BDI-II</measure>
    <time_frame>Within the first month after perinatal loss</time_frame>
    <description>Beck Depression Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BDI-II</measure>
    <time_frame>3 months after perinatal loss</time_frame>
    <description>Beck Depression Inventory</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Satisfaction survey</measure>
    <time_frame>3 months after perinatal loss</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pregnancy Loss</condition>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>EMDR-RTE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eye movement desensitization and reprocessing in its recent traumatic episode version.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual treatment by a psychologist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EMDR-RTE</intervention_name>
    <description>The experimental group will have EMDR recent traumatic event.</description>
    <arm_group_label>EMDR-RTE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TAU</intervention_name>
    <description>The comparator group will have usual psychological intervention.</description>
    <arm_group_label>TAU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  be over 18 years old&#xD;
&#xD;
          -  agree to participate and sign the informed consent&#xD;
&#xD;
          -  request psychological treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active substance use disorder&#xD;
&#xD;
          -  cognitive disability&#xD;
&#xD;
          -  language barrier&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anna Torres</last_name>
    <phone>+34 932279948</phone>
    <email>atorresg@clinic.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clinic sede Maternitat</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Torres Gim√©nez</last_name>
      <phone>932279948</phone>
      <email>atorresg@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>December 19, 2022</study_first_submitted>
  <study_first_submitted_qc>January 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2023</study_first_posted>
  <last_update_submitted>May 8, 2023</last_update_submitted>
  <last_update_submitted_qc>May 8, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>perinatal loss</keyword>
  <keyword>PTSD</keyword>
  <keyword>EMDR</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

